131 related articles for article (PubMed ID: 37922950)
1. Endometrioid Adenocarcinoma With "Burrowing" Invasion of the Cervix Represents a Separate Primary From the Concurrent Uterine Corpus Endometrial Endometrioid Adenocarcinoma: Histology, Immunohistochemistry, and Next-generation Sequencing Study of a Single Case.
Li Y; Chen J; Niu S
Int J Gynecol Pathol; 2024 May; 43(3):271-274. PubMed ID: 37922950
[TBL] [Abstract][Full Text] [Related]
2. Synchronous endometrioid adenocarcinomas in the uterine cervix and corpus.
Obata T; Nakamura M; Mizumoto Y; Matsumoto T; Takakura M; Fujiwara H
J Obstet Gynaecol Res; 2016 Oct; 42(10):1390-1394. PubMed ID: 27354119
[TBL] [Abstract][Full Text] [Related]
3. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
Tambouret R; Clement PB; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
[TBL] [Abstract][Full Text] [Related]
4. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
Taylor J; McCluggage WG
Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
[TBL] [Abstract][Full Text] [Related]
5. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
6. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
[TBL] [Abstract][Full Text] [Related]
7. Endometrioid carcinoma of the endometrium with an invasive component of minimal deviation carcinoma.
Mai KT; Perkins DG; Yazdi HM; Thomas J
Hum Pathol; 2002 Aug; 33(8):856-8. PubMed ID: 12203221
[TBL] [Abstract][Full Text] [Related]
8. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
[TBL] [Abstract][Full Text] [Related]
9. A Deceptive Spread: Myoinvasion of Endometrial Carcinoma Imitating Adenoma Malignum.
Deb PQ; Marcus JZ; Abedin Y; Heller DS
Int J Surg Pathol; 2020 May; 28(3):284-286. PubMed ID: 31690149
[TBL] [Abstract][Full Text] [Related]
10. Synchronously occurring endometrioid carcinomas of the uterine corpus and uterine cervix preceded by different precancerous lesions: A case study and a literature review.
Monist M; Lewkowicz D; Piętak P; Pilewska-Kozak A; Man YG; Semczuk A
Pathol Res Pract; 2023 May; 245():154452. PubMed ID: 37030165
[TBL] [Abstract][Full Text] [Related]
11. Endometrioid adenocarcinoma arising from endometriosis of the uterine cervix: a case report.
Park HM; Lee SS; Eom DW; Kang GH; Yi SW; Sohn WS
J Korean Med Sci; 2009 Aug; 24(4):767-71. PubMed ID: 19654969
[TBL] [Abstract][Full Text] [Related]
12. Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma.
Chapel DB; Patil SA; Plagov A; Puranik R; Mendybaeva A; Steinhardt G; Wanjari P; Lastra RR; Kadri S; Segal JP; Ritterhouse LL
Mod Pathol; 2019 Oct; 32(10):1508-1520. PubMed ID: 31186530
[TBL] [Abstract][Full Text] [Related]
13. [Uterine
Cao F; Zhong M; Liu CR
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):370-374. PubMed ID: 37042153
[TBL] [Abstract][Full Text] [Related]
14. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
[TBL] [Abstract][Full Text] [Related]
15. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
[TBL] [Abstract][Full Text] [Related]
16. Grossly unremarkable cervix in endometrial carcinomas: lymphovascular space invasion and microcystic elongated and fragmented pattern may be associated with high incidence of cervical stromal involvement.
Zhang Y; Jeyachandran D; Desouki MM
Hum Pathol; 2021 Jul; 113():59-66. PubMed ID: 33933559
[TBL] [Abstract][Full Text] [Related]
17. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
Fadare O; Parkash V
Diagn Pathol; 2017 Nov; 12(1):81. PubMed ID: 29137657
[TBL] [Abstract][Full Text] [Related]
18. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
19. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
20. Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus.
Ervine A; Leung S; Gilks CB; McCluggage WG
Histopathology; 2014 May; 64(6):840-6. PubMed ID: 24267480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
